blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2413719

EP2413719 - METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.05.2016
Database last updated on 31.08.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
UNIVERSITE D'ANGERS
40, rue de Rennes
49000 Angers / FR
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75013 Paris / FR
[2012/06]
Inventor(s)01 / BENOIT, Jean-Pierre
81 avenue René Gasnier
F-49100 Angers / FR
02 / PERRIER, Thomas
13 résidence Puy Garnier
F-49100 Angers / FR
 [2012/06]
Representative(s)Le Coupanec, Pascale A.M.P.
Nony
11 rue Saint-Georges
75009 Paris / FR
[N/P]
Former [2015/28]Le Coupanec, Pascale A.M.P.
Cabinet Nony
3, rue de Penthièvre
75008 Paris / FR
Former [2012/06]Le Coupanec, Pascale A.M.P.
Nony & Associés 3, rue de Penthièvre
75008 Paris / FR
Application number, filing date10714072.530.03.2010
WO2010IB51377
Priority number, dateFR2009005204831.03.2009         Original published format: FR 0952048
[2012/06]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO2010113111
Date:07.10.2010
Language:FR
[2010/40]
Type: A1 Application with search report 
No.:EP2413719
Date:08.02.2012
Language:FR
The application published by WIPO in one of the EPO official languages on 07.10.2010 takes the place of the publication of the European patent application.
[2012/06]
Type: B1 Patent specification 
No.:EP2413719
Date:08.07.2015
Language:FR
[2015/28]
Search report(s)International search report - published on:EP07.10.2010
ClassificationIPC:A61K9/51
[2015/04]
CPC:
A61K9/5123 (EP,US); A23L33/10 (EP,US); A23P10/35 (EP,US);
A61K47/6925 (EP,US); A61K8/11 (EP,US); A61K8/606 (EP,US);
A61K8/64 (EP,US); A61P25/00 (EP); A61P25/04 (EP);
A61P25/16 (EP); A61P25/28 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P31/10 (EP); A61P35/00 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61Q19/00 (EP,US);
A61K2800/413 (EP,US); A61K2800/612 (EP,US); Y10T428/2984 (EP,US) (-)
Former IPC [2012/06]A23L1/29, A61K8/11, A61K47/48, A61Q19/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/06]
Extension statesALNot yet paid
BANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON FUNKTIONALISIERTEN LIPIDKAPSELN[2012/06]
English:METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES[2012/06]
French:PROCEDE DE PREPARATION DE CAPSULES LIPIDIQUES FONCTIONNALISEES[2012/06]
Entry into regional phase23.09.2011National basic fee paid 
23.09.2011Designation fee(s) paid 
23.09.2011Examination fee paid 
Examination procedure23.09.2011Examination requested  [2012/06]
02.05.2012Amendment by applicant (claims and/or description)
27.01.2015Communication of intention to grant the patent
27.05.2015Fee for grant paid
27.05.2015Fee for publishing/printing paid
27.05.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.01.2015
Opposition(s)11.04.2016No opposition filed within time limit [2016/24]
Fees paidRenewal fee
23.02.2012Renewal fee patent year 03
02.04.2013Renewal fee patent year 04
31.03.2014Renewal fee patent year 05
24.03.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.03.2010
AT08.07.2015
BG08.07.2015
CY08.07.2015
CZ08.07.2015
DK08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MK08.07.2015
MT08.07.2015
PL08.07.2015
RO08.07.2015
SE08.07.2015
SI08.07.2015
SK08.07.2015
SM08.07.2015
TR08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
[2018/38]
Former [2018/29]HU30.03.2010
AT08.07.2015
CY08.07.2015
CZ08.07.2015
DK08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MK08.07.2015
MT08.07.2015
PL08.07.2015
RO08.07.2015
SE08.07.2015
SI08.07.2015
SK08.07.2015
SM08.07.2015
TR08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2018/28]HU30.03.2010
AT08.07.2015
CY08.07.2015
CZ08.07.2015
DK08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MK08.07.2015
MT08.07.2015
PL08.07.2015
RO08.07.2015
SE08.07.2015
SI08.07.2015
SK08.07.2015
SM08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2017/47]AT08.07.2015
CZ08.07.2015
DK08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MT08.07.2015
PL08.07.2015
RO08.07.2015
SE08.07.2015
SI08.07.2015
SK08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2016/36]AT08.07.2015
CZ08.07.2015
DK08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
RO08.07.2015
SE08.07.2015
SI08.07.2015
SK08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2016/23]AT08.07.2015
CZ08.07.2015
DK08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
RO08.07.2015
SE08.07.2015
SK08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2016/22]AT08.07.2015
CZ08.07.2015
DK08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
SE08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2016/20]AT08.07.2015
DK08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
SE08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2016/11]AT08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
SE08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2016/10]FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
SE08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
PT09.11.2015
Former [2016/09]FI08.07.2015
LT08.07.2015
LV08.07.2015
NO08.10.2015
GR09.10.2015
Former [2016/08]LT08.07.2015
NO08.10.2015
Former [2016/07]LT08.07.2015
Cited inInternational search[XI]FR2677272  (BIOVECTEURS AS [FR], et al) [X] 1-9,14,16-23 * the whole document * * claims 1,12 * * page 16, line 10 - page 17, line 28; examples 10,11 * [I] 1-23;
 [Y]US5635609  (LEVY MARIE-CHRISTINE [FR], et al) [Y] 1-23 * the whole document * * column 1, lines 7-25 ** claims 24,39 *;
 [Y]WO0164328  (MAINELAB [FR], et al) [Y] 1-23 * the whole document * * page 2, lines 22-31 * * page 6, lines 11-30 * * page 7, line 29 - page 8, line 8 * * page 18, line 4; examples 1,7 * * claims 1,5,6,10,13-16,20 *;
 [XI]US2007140965  (LANZA GREGORY [US], et al) [X] 1-9,14,16-23 * the whole document * * paragraphs [0043] , [0067] * * paragraphs [0058] - [0063] * * paragraphs [0002] , [0048] , [0079] , [0080] * [I] 1-23;
 [XI]US2007184076  (UNGER EVAN C [US], et al) [X] 1-9,14,16-23 * the whole document * * paragraphs [0039] , [0054] - [0059]; figure 1 * * claims 1,2,17,18 * [I] 1-23;
 [XI]WO2007106683  (UNIV PENNSYLVANIA [US], et al) [X] 1-9,14,16-23 * the whole document * * paragraphs [0002] , [0006] , [0031] , [0032] , [0050] , [0073] , [0086] , [0140] - [0143] - [0147] , [0155] , [0156] , [0161] - [0164]; figures 1a-1b; examples 1,2,5-8 * * claims 1,7-9,11,38-40 * [I] 1-23;
 [XI]US2008160094  (NELSON THOMAS [US], et al) [X] 1-9,14,16-23 * the whole document * * paragraphs [0002] , [0058] , [0062] , [0070] , [0082] , [0083]; claims 1,4-6,22,23 * [I] 1-23;
 [XI]US2008253960  (ZHENG GANG [US], et al) [X] 1-9,14,16-23 * the whole document * * figures 1,17 * * paragraphs [0002] , [0004] , [0012] , [0031] , [0036] - [0039] - [0042] , [0043] , [0047] , [0050] , [0051] , [0128] , [0137] - [0139] - [0195]; table 1 * * paragraphs [0195] - [0199] - [0248] - [0252]; examples 7,10; claims 1-4,48,49,52,55 * [I] 1-23
by applicant   - MOSMANN T, JOURNAL OFIMMUNOLOGICAL METHODS, (198312), vol. 65, no. 1-2, pages 55 - 63
    - CORY ET AL., CANCER COMMUNICATIONS, (199107), vol. 3, no. 7, pages 207 - 12
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.